Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 63
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 3101 | SIRNAOMICS | 5 | 00% | 5 | 0 | 2022–2022 |
| 3102 | SKAN | 5 | 00% | 1 | 4 | 2022–2022 |
| 3103 | SKYSAFE | 5 | 240% | 1 | 2 | 2021–2025 |
| 3104 | SNAP ON | 5 | 360% | 0 | 2 | 2021–2025 |
| 3105 | SOCI T BIC | 5 | 120% | 0 | 4 | 2022–2023 |
| 3106 | SOLASTA BIO | 5 | 00% | 0 | 5 | 2024–2025 |
| 3107 | SOLETANCHE FREYSSINET | 5 | 00% | 1 | 4 | 2022–2023 |
| 3108 | SOLIDIA TECHNOLOGIES | 5 | 120% | 2 | 2 | 2022–2024 |
| 3109 | SOLVENTUM INTELLECTUAL PROPERTIES | 5 | 120% | 0 | 4 | 2023–2025 |
| 3110 | SOMERO ENTERPRISES | 5 | 00% | 0 | 5 | 2022–2025 |
| 3111 | SOTER BIOPHARMA | 5 | 120% | 0 | 4 | 2023–2024 |
| 3112 | SPAGO NANOMEDICAL | 5 | 120% | 0 | 4 | 2022–2024 |
| 3113 | SPECTRAL MD | 5 | 00% | 0 | 5 | 2022–2024 |
| 3114 | SPEIRA | 5 | 360% | 0 | 2 | 2022–2024 |
| 3115 | STANADYNE OPERATING | 5 | 00% | 0 | 5 | 2023–2025 |
| 3116 | STARK FUTURE S L | 5 | 00% | 0 | 5 | 2023–2023 |
| 3117 | SUNIA | 5 | 00% | 0 | 5 | 2023–2024 |
| 3118 | SUPERTAB | 5 | 00% | 0 | 5 | 2023–2025 |
| 3119 | SUSTECH | 5 | 00% | 0 | 5 | 2024–2026 |
| 3120 | SUZANO | 5 | 00% | 0 | 5 | 2023–2025 |
| 3121 | SUZHOU ABOGEN BIOSCIENCES | 5 | 120% | 0 | 4 | 2022–2026 |
| 3122 | SWISS PERFORMANCE CHEMICALS | 5 | 00% | 0 | 5 | 2024–2025 |
| 3123 | SYNTHON | 5 | 00% | 1 | 4 | 2022–2025 |
| 3124 | SYZYGY PLASMONICS | 5 | 00% | 0 | 5 | 2023–2025 |
| 3125 | T G MEDICAL | 5 | 120% | 0 | 4 | 2020–2025 |
| 3126 | TAIF JOINT STOCK | 5 | 00% | 0 | 5 | 2023–2024 |
| 3127 | TAISEI KAKO | 5 | 00% | 0 | 5 | 2023–2025 |
| 3128 | TALLANO TECHNOLOGIE | 5 | 480% | 0 | 1 | 2021–2022 |
| 3129 | TANNPAPIER | 5 | 00% | 0 | 5 | 2023–2025 |
| 3130 | TARGIMMUNE THERAPEUTICS | 5 | 00% | 0 | 5 | 2023–2025 |
| 3131 | TBCASOFT | 5 | 00% | 0 | 5 | 2023–2026 |
| 3132 | TCL TECHNOLOGY GROUP | 5 | 5100% | 0 | 0 | 2022–2022 |
| 3133 | TENAYA THERAPEUTICS | 5 | 00% | 2 | 3 | 2022–2024 |
| 3134 | TERABASE ENERGY | 5 | 00% | 0 | 5 | 2024–2026 |
| 3135 | TERVIVA | 5 | 00% | 1 | 4 | 2022–2024 |
| 3136 | TFL LEDERTECHNIK | 5 | 00% | 0 | 5 | 2023–2026 |
| 3137 | THE AES | 5 | 00% | 1 | 4 | 2022–2025 |
| 3138 | THE NIPPON SIGNAL | 5 | 120% | 0 | 4 | 2022–2024 |
| 3139 | THEION | 5 | 120% | 0 | 4 | 2022–2026 |
| 3140 | THERAS | 5 | 00% | 0 | 5 | 2023–2026 |
| 3141 | THYSSENKRUPP INDUSTRIAL SOLUTIONS | 5 | 120% | 0 | 4 | 2022–2023 |
| 3142 | TIANMULAKE EXCELLENT ANODE MATERIALS | 5 | 00% | 0 | 5 | 2023–2024 |
| 3143 | TOTAL VEHICLE SOLUTIONS GROUP | 5 | 00% | 0 | 5 | 2025–2025 |
| 3144 | TOTO | 5 | 00% | 0 | 5 | 2022–2025 |
| 3145 | TOYO KOHAN | 5 | 00% | 0 | 5 | 2024–2026 |
| 3146 | TPI COMPOSITES | 5 | 00% | 0 | 5 | 2022–2023 |
| 3147 | TRADING TECHNOLOGIES INTERNATIONAL | 5 | 00% | 0 | 5 | 2025–2026 |
| 3148 | TRAMES BIO | 5 | 00% | 1 | 4 | 2023–2024 |
| 3149 | TRANSCEND THERAPEUTICS | 5 | 00% | 0 | 5 | 2024–2025 |
| 3150 | TRANSTHERA SCIENCES NANJING | 5 | 00% | 0 | 5 | 2022–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →